Has Sheila Cai received payments from drug or device companies?

Yes. Drug and device makers reported $8,020 in general payments to Sheila Cai across 319 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sheila Cai did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sheila Cai come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sheila Cai

Psychiatry · San Marcos, CANPI 1780625012

Payments from drug & device makers

$8,020in general payments, 2019–2025

Across 319 payments — averaging $25.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
Sunovion Pharmaceuticals Inc.$1K
Otsuka America Pharmaceutical, Inc.$857
Alkermes, Inc.$845
Johnson & Johnson$753
Lundbeck LLC$611
plus $2K from 14 others

What the payments were for

Food & beverage$7,86398%
Education$1572%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	59	$1,597
Sunovion Pharmaceuticals Inc.	64	$1,067
Otsuka America Pharmaceutical, Inc.	30	$857
Alkermes, Inc.	23	$845
Johnson & Johnson	27	$753
Lundbeck LLC	34	$611
Supernus Pharmaceuticals, Inc.	22	$596
AbbVie(2 entities)	19	$343
Vanda Pharmaceuticals Inc.	9	$340
E.r. Squibb & Sons, L.L.C.	6	$200
Teva Pharmaceuticals USA, Inc.	8	$200
Phathom Pharmaceuticals, Inc.	1	$125
Corcept Therapeutics	1	$104
Axsome Therapeutics, Inc.	1	$94
Neurocrine Biosciences, Inc.	4	$93
Takeda Pharmaceuticals U.S.A., Inc.	3	$53
Idorsia Pharmaceuticals US Inc	3	$49
Collegium Pharmaceutical, Inc.	2	$34
Ironshore Pharmaceuticals Inc.	2	$34
Indivior Inc.	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,020 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
RexultiBrexpiprazole	42	$59,501
Abilify MaintenaAripiprazole	14	$40,420
CaplytaLumateperone Tosylate	16	$34,102
VraylarCariprazine Hcl	13	$18,068
Aripiprazole	126	$15,145
Bupropion XlBupropion Hcl	131	$1,910
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	38	$1,838
Quetiapine Fumarate	136	$1,835
Venlafaxine Hcl ErVenlafaxine Hcl	89	$1,719
Lurasidone Hcl	25	$1,580
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	26	$1,449
Trazodone Hcl	147	$941
Propranolol Hcl	41	$818
Escitalopram Oxalate	116	$767
Sertraline Hcl	51	$727

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena	$857	$99,92156 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$1,597	$34,10216 claims
AbbVieVraylar	$343	$18,06813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,954 psychiatry providers in California.

Other psychiatry in San Marcos

Elly LeeIrvine$49.8M
Daniel ChuehOrange$17.9M
Eric ChavezSan Diego$15.5M
Lara ShirikjianTorrance$12.6M
John DuffySanta Ana$12M
Marina BusselPlaya Vista$12M
Sherry SoefjeOceanside$11.9M
Steven MacinaHuntington Beach$11.1M
Wakelin McNeelRosemead$11M
Donald AndersonBanning$10.5M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →